🇺🇸 FDA
Patent

US 9345748

Anti-SSX-2 T cell receptors and related materials and methods of use

granted A61KA61K31/706A61K38/08

Quick answer

US patent 9345748 (Anti-SSX-2 T cell receptors and related materials and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/706, A61K38/08, A61K38/10, A61K38/177